Elevance Health raises 2026 guidance as Elevance Health stock trades at EUR 393.10
Published on 10/24/2026 at 10:20 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSGuidance and trading dates
- Elevance Health raised its minimum adjusted earnings guidance for 2026 to USD 29.00 on October 21, 2026.
- Elevance Health stock trades in weekend trading at Lang & Schwarz at EUR 393.10 at 10:15 a.m. CEST on October 24, 2026.
- The next Xetra session is scheduled for October 26, 2026.
Elevance Health raised its 2026 full-year earnings guidance on October 21, 2026, according to the company's press release. Elevance Health stock trades at EUR 393.10 in weekend trading at Lang & Schwarz at 10:15 a.m. CEST on October 24, 2026.
Market context: Market report S&P 500.
The week in figures
Elevance Health reported operating revenue of USD 50.40 billion in the third quarter of 2026, up 0.70 percent from the prior-year quarter. Diluted earnings per share were USD 6.27, while adjusted diluted earnings per share were USD 6.99. The company also raised its minimum 2026 adjusted diluted earnings guidance to USD 29.00 per share and its operating cash flow guidance to at least USD 6.50 billion.
Weekend trading
The EUR 393.10 indication is the current weekend-trading price at Lang & Schwarz. The venue reported a bid of EUR 392.30 and an ask of EUR 393.90 at the 10:15 a.m. CEST timestamp on October 24, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Elevance Health stock.
Chronology of the week
On October 21, 2026, Elevance Health, Inc. reported results for the quarter ended September 30, 2026 in a filing with the U.S. Securities and Exchange Commission. The filing identifies the company’s common stock under the ticker ELV on the New York Stock Exchange.
Dates of the coming week
The next Xetra session is scheduled for October 26, 2026. The company’s fourth-quarter 2026 dividend of USD 1.72 per share is payable on December 18, 2026 to shareholders of record at the close of business on December 4, 2026, according to the company’s release.
